Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study

Chih Hung Hsu, Yoon Koo Kang, Tsai Shen Yang, Chia Tung Shun, Yu Yun Shao, Wu Chou Su, Jennifer Sandoval-Tan, Tzeon Jye Chiou, Kate Jin, Chiun Hsu, Ann Lii Cheng

研究成果: 雜誌貢獻 › 文章 › 同行評審